Listar Ciencias de la Salud por tema "Multikinase inhibitors"
Mostrando ítems 1-1 de 1
-
Neoadjuvant multikinase inhibitor in patients with locally advanced unresectable thyroid carcinoma
(2019) [Artículo de periódico]Background: Papillary thyroid carcinoma (PTC) is the most common and less aggressive thyroid cancer, but some patients may display locally advanced disease. Therapeutic options are limited in these cases, particularly for ...